Literature DB >> 12654853

Polymorphisms within EspA filaments of enteropathogenic and enterohemorrhagic Escherichia coli.

Bianca C Neves1, Robert K Shaw, Gad Frankel, Stuart Knutton.   

Abstract

Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) possess a filamentous type III secretion system (TTSS) employed to deliver effector proteins into host cells. EspA is a type III secreted protein which forms the filamentous extension to the TTSS and which interacts with host cells during early stages of attaching and effacing (A/E) lesion formation. By immunofluorescence, a polyclonal antibody previously raised to EspA from EPEC strain E2348/69 (O127:H6) stained approximately 12-nm-diameter EspA filaments produced by this strain but did not stain similar filaments produced by EHEC serotype O157:H7. Similarly, an antibody that we subsequently raised to EHEC strain 85-170 (O157:H7) EspA stained approximately 12-nm-diameter EspA filaments produced by strain 85-170 but did not stain E2348/69 EspA filaments. Given such heterogeneity between EPEC and EHEC EspA filaments, we examined polymorphisms of functional EspA filaments among different EPEC and EHEC serotypes. With use of the EPEC EspA antiserum, EspA filaments were observed only with EPEC serotypes O127:H6 and O55:H6, serotypes which encode an identical EspA protein. When stained with the EHEC EspA antiserum, EspA filaments were detected only on EHEC strains belonging to serotype O157:H7; the EHEC antiserum did, however, stain EspA filaments produced by the closely related EPEC serotype O55:H7 but not filaments of any other EPEC serotype tested. Such polymorphisms among functional EspA filaments of EPEC and EHEC would be expected to have important implications for the development of broad-range EspA-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654853      PMCID: PMC152064          DOI: 10.1128/IAI.71.4.2262-2265.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  EspA filament-mediated protein translocation into red blood cells.

Authors:  R K Shaw; S Daniell; F Ebel; G Frankel; S Knutton
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

2.  The filamentous type III secretion translocon of enteropathogenic Escherichia coli.

Authors:  S J Daniell; N Takahashi; R Wilson; D Friedberg; I Rosenshine; F P Booy; R K Shaw; S Knutton; G Frankel; S Aizawa
Journal:  Cell Microbiol       Date:  2001-12       Impact factor: 3.715

3.  Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria.

Authors:  B Kenny; M Jepson
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

4.  Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa.

Authors:  S Knutton; D R Lloyd; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

5.  Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.

Authors:  S Tzipori; H Karch; K I Wachsmuth; R M Robins-Browne; A D O'Brien; H Lior; M L Cohen; J Smithers; M M Levine
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.

Authors:  S J Elliott; E O Krejany; J L Mellies; R M Robins-Browne; C Sasakawa; J B Kaper
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.

Authors:  H W Moon; S C Whipp; R A Argenzio; M M Levine; R A Giannella
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more
  12 in total

1.  Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes.

Authors:  Sivan Dahan; Stuart Knutton; Robert K Shaw; Valerie F Crepin; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion.

Authors:  Valérie F Crepin; Robert Shaw; Cecilia M Abe; Stuart Knutton; Gad Frankel
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

3.  Enterohemorrhagic Escherichia coli exploits EspA filaments for attachment to salad leaves.

Authors:  Robert K Shaw; Cedric N Berger; Bart Feys; Stuart Knutton; Mark J Pallen; Gad Frankel
Journal:  Appl Environ Microbiol       Date:  2008-02-29       Impact factor: 4.792

4.  The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.

Authors:  Thomas E Grys; Matthew B Siegel; Wyndham W Lathem; Rodney A Welch
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli.

Authors:  Daniel A Vilte; Mariano Larzábal; Angel A Cataldi; Elsa C Mercado
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

6.  Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7.

Authors:  Sarah A Kühne; William S Hawes; Roberto M La Ragione; Martin J Woodward; Garry C Whitelam; Kevin C Gough
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.

Authors:  Francis Girard; Valérie F Crepin; Gad Frankel
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

8.  Epidemiological survey on Escherichia coli O157 in Chongqing and Three-Gorge Reservoir Areas of China.

Authors:  Haoju Wang; Xuhu Mao; Honglei Ding; Quanming Zou; Xiao Peng
Journal:  Vet Res Commun       Date:  2008-05-15       Impact factor: 2.459

9.  Clonal relationship among atypical enteropathogenic Escherichia coli strains isolated from different animal species and humans.

Authors:  Rodrigo A Moura; Marcelo P Sircili; Luciana Leomil; Maria Helena Matté; Luiz R Trabulsi; Waldir P Elias; Kinue Irino; Antonio F Pestana de Castro
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

10.  Cryoelectron-microscopy structure of the enteropathogenic Escherichia coli type III secretion system EspA filament.

Authors:  Weili Zheng; Alejandro Peña; Aravindan Ilangovan; Jasmine Naemi-Baghshomali Clark; Gad Frankel; Edward H Egelman; Tiago R D Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.